{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T01:20:29Z","timestamp":1791249629411,"version":"4.1.0"},"reference-count":37,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2016,5,1]],"date-time":"2016-05-01T00:00:00Z","timestamp":1462060800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2016,2,3]],"date-time":"2016-02-03T00:00:00Z","timestamp":1454457600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["jidonline.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Investigative Dermatology"],"published-print":{"date-parts":[[2016,5]]},"DOI":"10.1016\/j.jid.2015.12.042","type":"journal-article","created":{"date-parts":[[2016,1,29]],"date-time":"2016-01-29T12:00:19Z","timestamp":1454068819000},"page":"994-1001","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":35,"title":["Immunophenotyping of Stage III Melanoma Reveals Parameters Associated with Patient Prognosis"],"prefix":"10.1016","volume":"136","author":[{"given":"Nicolas","family":"Jacquelot","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mar\u00eda Paula","family":"Roberti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David P.","family":"Enot","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sylvie","family":"Rusakiewicz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michaela","family":"Semeraro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sarah","family":"J\u00e9gou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Camila","family":"Flores","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lieping","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Byoung S.","family":"Kwon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christophe","family":"Borg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Benjamin","family":"Weide","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fran\u00e7ois","family":"Aubin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"St\u00e9phane","family":"Dalle","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Holbrook","family":"Kohrt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maha","family":"Ayyoub","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guido","family":"Kroemer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aur\u00e9lien","family":"Marabelle","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andr\u00e9a","family":"Cavalcanti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexander","family":"Eggermont","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laurence","family":"Zitvogel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jid.2015.12.042_bib1","doi-asserted-by":"crossref","first-page":"1537","DOI":"10.1182\/blood-2008-12-195792","article-title":"Tumor antigen-specific CD8 T cells infiltrating the tumor express high levels of PD-1 and are functionally impaired","volume":"114","author":"Ahmadzadeh","year":"2009","journal-title":"Blood"},{"key":"10.1016\/j.jid.2015.12.042_bib2","doi-asserted-by":"crossref","first-page":"5639","DOI":"10.1038\/ncomms6639","article-title":"Enrichment of CD56(dim)KIR\u00a0+ CD57\u00a0+ highly cytotoxic NK cells in tumour-infiltrated lymph nodes of melanoma patients","volume":"5","author":"Ali","year":"2014","journal-title":"Nat Commun"},{"key":"10.1016\/j.jid.2015.12.042_bib3","doi-asserted-by":"crossref","first-page":"2350","DOI":"10.1172\/JCI46102","article-title":"Exhaustion of tumor-specific CD8+ T cells in metastases from melanoma patients","volume":"121","author":"Baitsch","year":"2011","journal-title":"J\u00a0Clin Invest"},{"key":"10.1016\/j.jid.2015.12.042_bib4","doi-asserted-by":"crossref","first-page":"6199","DOI":"10.1200\/JCO.2009.23.4799","article-title":"Final version of 2009 AJCC melanoma staging and classification","volume":"27","author":"Balch","year":"2009","journal-title":"J\u00a0Clin Oncol Off J Am Soc Clin Oncol"},{"key":"10.1016\/j.jid.2015.12.042_bib5","doi-asserted-by":"crossref","first-page":"2452","DOI":"10.1200\/JCO.2009.27.1627","article-title":"Multivariate analysis of prognostic factors among 2,313 patients with stage III melanoma: comparison of nodal micrometastases versus macrometastases","volume":"28","author":"Balch","year":"2010","journal-title":"J\u00a0Clin Oncol"},{"key":"10.1016\/j.jid.2015.12.042_bib6","doi-asserted-by":"crossref","first-page":"20429","DOI":"10.1073\/pnas.0905139106","article-title":"Immune profile and mitotic index of metastatic melanoma lesions enhance clinical staging in predicting patient survival","volume":"106","author":"Bogunovic","year":"2009","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.jid.2015.12.042_bib7","doi-asserted-by":"crossref","first-page":"5213","DOI":"10.1158\/0008-5472.CAN-10-0118","article-title":"Selective BRAFV600E inhibition enhances T-cell recognition of melanoma without affecting lymphocyte function","volume":"70","author":"Boni","year":"2010","journal-title":"Cancer Res"},{"key":"10.1016\/j.jid.2015.12.042_bib8","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1586\/14737159.2014.928206","article-title":"Immune cells in the melanoma microenvironment hold information for prediction of the risk of recurrence and response to treatment","volume":"14","author":"Camisaschi","year":"2014","journal-title":"Expert Rev Mol Diagn"},{"key":"10.1016\/j.jid.2015.12.042_bib9","doi-asserted-by":"crossref","first-page":"2507","DOI":"10.1056\/NEJMoa1103782","article-title":"Improved survival with vemurafenib in melanoma with BRAF V600E mutation","volume":"364","author":"Chapman","year":"2011","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jid.2015.12.042_bib10","first-page":"1529","article-title":"Phenotypic analysis of tumor-infiltrating lymphocytes in hepatocellular carcinoma","volume":"54","author":"Chen","year":"2007","journal-title":"Hepatogastroenterology"},{"key":"10.1016\/j.jid.2015.12.042_bib11","doi-asserted-by":"crossref","first-page":"e982382","DOI":"10.4161\/2162402X.2014.982382","article-title":"Characterization of the in\u00a0vivo immune network of IDO, tryptophan metabolism, PD-L1, and CTLA-4 in circulating immune cells in melanoma","volume":"4","author":"Chevolet","year":"2015","journal-title":"Oncoimmunology"},{"key":"10.1016\/j.jid.2015.12.042_bib12","doi-asserted-by":"crossref","first-page":"e26615","DOI":"10.4161\/onci.26615","article-title":"BRAF inhibition is associated with increased clonality in tumor-infiltrating lymphocytes","volume":"2","author":"Cooper","year":"2013","journal-title":"Oncoimmunology"},{"key":"10.1016\/j.jid.2015.12.042_bib13","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1038\/35093109","article-title":"Rae1 and H60 ligands of the NKG2D receptor stimulate tumour immunity","volume":"413","author":"Diefenbach","year":"2001","journal-title":"Nature"},{"key":"10.1016\/j.jid.2015.12.042_bib14","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1053\/j.seminoncol.2015.02.010","article-title":"Immune checkpoint inhibitors in melanoma provide the cornerstones for curative therapies","volume":"42","author":"Eggermont","year":"2015","journal-title":"Semin Oncol"},{"key":"10.1016\/j.jid.2015.12.042_bib15","doi-asserted-by":"crossref","first-page":"816","DOI":"10.1016\/S0140-6736(13)60802-8","article-title":"Cutaneous melanoma","volume":"383","author":"Eggermont","year":"2014","journal-title":"Lancet"},{"key":"10.1016\/j.jid.2015.12.042_bib16","doi-asserted-by":"crossref","first-page":"3825","DOI":"10.1158\/1078-0432.CCR-07-0358","article-title":"Long-term protective effect of mature DC-LAMP+ dendritic cell accumulation in sentinel lymph nodes containing micrometastatic melanoma","volume":"13","author":"Elliott","year":"2007","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.jid.2015.12.042_bib17","doi-asserted-by":"crossref","first-page":"1070","DOI":"10.1158\/0008-5472.CAN-11-3218","article-title":"Immunotype and immunohistologic characteristics of tumor-infiltrating immune cells are associated with clinical outcome in metastatic melanoma","volume":"72","author":"Erdag","year":"2012","journal-title":"Cancer Res"},{"key":"10.1016\/j.jid.2015.12.042_bib18","doi-asserted-by":"crossref","first-page":"1225","DOI":"10.1158\/1078-0432.CCR-12-1630","article-title":"BRAF inhibition is associated with enhanced melanoma antigen expression and a more favorable tumor microenvironment in patients with metastatic melanoma","volume":"19","author":"Frederick","year":"2013","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.jid.2015.12.042_bib19","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1016\/S0140-6736(12)60868-X","article-title":"Dabrafenib in BRAF-mutated metastatic melanoma: a multicentre, open-label, phase 3 randomised controlled trial","volume":"380","author":"Hauschild","year":"2012","journal-title":"Lancet"},{"key":"10.1016\/j.jid.2015.12.042_bib20","doi-asserted-by":"crossref","first-page":"598","DOI":"10.1158\/1078-0432.CCR-12-2731","article-title":"The activation of MAPK in melanoma cells resistant to BRAF inhibition promotes PD-L1 expression that is reversible by MEK and PI3K inhibition","volume":"19","author":"Jiang","year":"2013","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.jid.2015.12.042_bib21","doi-asserted-by":"crossref","first-page":"3052","DOI":"10.1158\/1078-0432.CCR-14-3073","article-title":"Characterization of PD-L1 expression and associated T-cell infiltrates in metastatic melanoma samples from variable anatomic sites","volume":"21","author":"Kluger","year":"2015","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.jid.2015.12.042_bib22","doi-asserted-by":"crossref","first-page":"1450","DOI":"10.1182\/blood-2014-03-563940","article-title":"Accumulation of 4-1BBL+ B cells in the elderly induces the generation of granzyme-B+ CD8+ T cells with potential antitumor activity","volume":"124","author":"Lee-Chang","year":"2014","journal-title":"Blood"},{"key":"10.1016\/j.jid.2015.12.042_bib23","doi-asserted-by":"crossref","first-page":"1980","DOI":"10.1093\/annonc\/mdv255","article-title":"The status of PD-L1 and tumor-infiltrating immune cells predict resistance and poor prognosis in BRAFi-treated melanoma patients harboring mutant BRAFV600","volume":"26","author":"Massi","year":"2015","journal-title":"Ann Oncol"},{"key":"10.1016\/j.jid.2015.12.042_bib24","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1158\/0008-5472.CAN-13-1303","article-title":"Mature cytotoxic CD56(bright)\/CD16(+) natural killer cells can infiltrate lymph nodes adjacent to metastatic melanoma","volume":"74","author":"Messaoudene","year":"2014","journal-title":"Cancer Res"},{"key":"10.1016\/j.jid.2015.12.042_bib25","first-page":"43","article-title":"Tumor infiltrating lymphocytes in lymph node melanoma metastases: a histopathologic prognostic indicator and an expression of local immune response","volume":"74","author":"Mihm","year":"1996","journal-title":"Lab Invest"},{"key":"10.1016\/j.jid.2015.12.042_bib26","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1186\/1479-5876-11-43","article-title":"Immune cell profile of sentinel lymph nodes in patients with malignant melanoma: FOXP3+ cell density in cases with positive sentinel node status is associated with unfavorable clinical outcome","volume":"11","author":"Mohos","year":"2013","journal-title":"J\u00a0Transl Med"},{"key":"10.1016\/j.jid.2015.12.042_bib27","first-page":"3","article-title":"Focus on TILs: prognostic significance of tumor infiltrating lymphocytes in human melanoma","volume":"9","author":"Oble","year":"2009","journal-title":"Cancer Immun"},{"key":"10.1016\/j.jid.2015.12.042_bib28","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1007\/s00262-012-1389-z","article-title":"Inhibition of both BRAF and MEK in BRAF(V600E) mutant melanoma restores compromised dendritic cell (DC) function while having differential direct effects on DC properties","volume":"62","author":"Ott","year":"2013","journal-title":"Cancer Immunol Immunother"},{"key":"10.1016\/j.jid.2015.12.042_bib29","doi-asserted-by":"crossref","first-page":"5208","DOI":"10.1158\/1078-0432.CCR-09-0886","article-title":"Differential clinical significance of individual NKG2D ligands in melanoma: soluble ULBP2 as an indicator of poor prognosis superior to S100B","volume":"15","author":"Paschen","year":"2009","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.jid.2015.12.042_bib30","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1158\/0008-5472.CAN-13-1186","article-title":"Regulation of CD4(+)NKG2D(+) Th1 cells in patients with metastatic melanoma treated with sorafenib: role of IL-15R\u03b1 and NKG2D triggering","volume":"74","author":"Romero","year":"2014","journal-title":"Cancer Res"},{"key":"10.1016\/j.jid.2015.12.042_bib31","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1007\/s00262-005-0023-8","article-title":"Identification of identical TCRs in primary melanoma lesions and tumor free corresponding sentinel lymph nodes","volume":"55","author":"Straten","year":"2006","journal-title":"Cancer Immunol Immunother"},{"key":"10.1016\/j.jid.2015.12.042_bib32","doi-asserted-by":"crossref","first-page":"1651","DOI":"10.1084\/jem.20051848","article-title":"The BRAF-MAPK signaling pathway is essential for cancer-immune evasion in human melanoma cells","volume":"203","author":"Sumimoto","year":"2006","journal-title":"J\u00a0Exp Med"},{"key":"10.1016\/j.jid.2015.12.042_bib33","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1126\/scitranslmed.3003689","article-title":"Colocalization of inflammatory response with B7-h1 expression in human melanocytic lesions supports an adaptive resistance mechanism of immune escape","volume":"4","author":"Taube","year":"2012","journal-title":"Sci Transl Med"},{"key":"10.1016\/j.jid.2015.12.042_bib34","doi-asserted-by":"crossref","first-page":"2199","DOI":"10.1200\/JCO.2010.31.5812","article-title":"Prognostic significance of mitotic rate in localized primary cutaneous melanoma: an analysis of patients in the multi-institutional American Joint Committee on Cancer melanoma staging database","volume":"29","author":"Thompson","year":"2011","journal-title":"J\u00a0Clin Oncol"},{"key":"10.1016\/j.jid.2015.12.042_bib35","doi-asserted-by":"crossref","first-page":"568","DOI":"10.1038\/nature13954","article-title":"PD-1 blockade induces responses by inhibiting adaptive immune resistance","volume":"515","author":"Tumeh","year":"2014","journal-title":"Nature"},{"key":"10.1016\/j.jid.2015.12.042_bib36","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1158\/0008-5472.CAN-13-1672","article-title":"Transcriptional profiling of melanoma sentinel nodes identify patients with poor outcome and reveal an association of CD30(+) T lymphocytes with progression","volume":"74","author":"Vallacchi","year":"2014","journal-title":"Cancer Res"},{"key":"10.1016\/j.jid.2015.12.042_bib37","doi-asserted-by":"crossref","first-page":"2520","DOI":"10.1158\/0008-5472.CAN-05-2520","article-title":"Proteolytic release of soluble UL16-binding protein 2 from tumor cells","volume":"66","author":"Waldhauer","year":"2006","journal-title":"Cancer Res"}],"container-title":["Journal of Investigative Dermatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022202X16003663?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022202X16003663?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,11,22]],"date-time":"2018-11-22T20:42:53Z","timestamp":1542919373000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0022202X16003663"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,5]]},"references-count":37,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2016,5]]}},"alternative-id":["S0022202X16003663"],"URL":"https:\/\/doi.org\/10.1016\/j.jid.2015.12.042","relation":{},"ISSN":["0022-202X"],"issn-type":[{"value":"0022-202X","type":"print"}],"subject":[],"published":{"date-parts":[[2016,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Immunophenotyping of Stage III Melanoma Reveals Parameters Associated with Patient Prognosis","name":"articletitle","label":"Article Title"},{"value":"Journal of Investigative Dermatology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jid.2015.12.042","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2016 The Authors. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}